Virginia L. Wyss

733 total citations
24 papers, 472 citations indexed

About

Virginia L. Wyss is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Virginia L. Wyss has authored 24 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Virginia L. Wyss's work include Cardiac electrophysiology and arrhythmias (5 papers), Synthesis and Reactions of Organic Compounds (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Virginia L. Wyss is often cited by papers focused on Cardiac electrophysiology and arrhythmias (5 papers), Synthesis and Reactions of Organic Compounds (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Virginia L. Wyss collaborates with scholars based in United States, Italy and Canada. Virginia L. Wyss's co-authors include Joseph A. Jakubowski, J S Hayes, Eddie L. Angleton, Kwan Y. Hui, Harve Wilson, David W. Robertson, Joseph H. Krushinski, Nancy Bowling, Peter J. Gengo and Mitchell I. Steinberg and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Virginia L. Wyss

24 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia L. Wyss United States 11 194 114 98 82 49 24 472
YOSHIO YOSHIOKA Japan 10 194 1.0× 115 1.0× 53 0.5× 38 0.5× 80 1.6× 15 466
Snezana Mirkov United States 15 310 1.6× 143 1.3× 29 0.3× 21 0.3× 35 0.7× 24 801
Arthur S. Brecher United States 14 181 0.9× 18 0.2× 112 1.1× 56 0.7× 41 0.8× 65 539
B. H. Tan United States 14 219 1.1× 27 0.2× 55 0.6× 40 0.5× 82 1.7× 22 477
Hongyu Qiu China 13 304 1.6× 43 0.4× 64 0.7× 8 0.1× 60 1.2× 42 701
N. Kitrossky Israel 7 107 0.6× 33 0.3× 36 0.4× 19 0.2× 59 1.2× 9 359
Pedro M. Politi United States 10 181 0.9× 41 0.4× 186 1.9× 13 0.2× 21 0.4× 18 466
Gerhard H. Scholz Germany 17 403 2.1× 62 0.5× 83 0.8× 13 0.2× 99 2.0× 39 958
V. Monzani Italy 7 277 1.4× 22 0.2× 69 0.7× 21 0.3× 39 0.8× 11 433
Hideki Mitsuhashi Japan 13 165 0.9× 22 0.2× 26 0.3× 26 0.3× 89 1.8× 25 641

Countries citing papers authored by Virginia L. Wyss

Since Specialization
Citations

This map shows the geographic impact of Virginia L. Wyss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia L. Wyss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia L. Wyss more than expected).

Fields of papers citing papers by Virginia L. Wyss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia L. Wyss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia L. Wyss. The network helps show where Virginia L. Wyss may publish in the future.

Co-authorship network of co-authors of Virginia L. Wyss

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia L. Wyss. A scholar is included among the top collaborators of Virginia L. Wyss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia L. Wyss. Virginia L. Wyss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wyss, Virginia L., et al.. (2004). 13. Assessment of Severe Sepsis in Children: Experiences from Pediatric Patients Receiving Drotrecogin Alfa (Activated). Journal of Emergency Nursing. 30(5). 409–409. 1 indexed citations
3.
Takeuchi, Kumiko, Todd J. Kohn, Dale E. Mais, et al.. (1998). Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 2. Design, synthesis, and evaluation of a novel series of phenyl oxazole derivatives. Bioorganic & Medicinal Chemistry Letters. 8(15). 1943–1948. 6 indexed citations
4.
Sall, Daniel J., Ann Arfsten, Jefferson R. McCowan, et al.. (1997). Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists. Journal of Medicinal Chemistry. 40(18). 2843–2857. 15 indexed citations
5.
6.
Hui, Kwan Y., Joseph A. Jakubowski, Virginia L. Wyss, & Eddie L. Angleton. (1992). Minimal sequence requirement of thrombin receptor agonist peptide. Biochemical and Biophysical Research Communications. 184(2). 790–796. 79 indexed citations
7.
Horng, Jong S., et al.. (1991). Atrial natriuretic peptide modulators: Dissociation of receptor binding and particulate guanylate cyclase activity. Drug Development Research. 23(3). 237–252. 1 indexed citations
8.
Bowling, Nancy, Virginia L. Wyss, Peter J. Gengo, et al.. (1990). Cardiac inotropic responses to calcium and forskolin are not altered by prolonged isoproterenol infusion. European Journal of Pharmacology. 187(2). 155–164. 8 indexed citations
9.
Yu, Melvin J., et al.. (1990). Atrial natriuretic peptide receptor modulators: effects of disubstituted quinazolines on receptor binding and in vitro biological activity. Journal of Medicinal Chemistry. 33(1). 348–353. 3 indexed citations
10.
11.
Wyss, Virginia L., et al.. (1990). Effects of L-carnitine administration on $$\dot V_{o_{2{\text{ }}max} } $$ and the aerobic-anaerobic threshold in normoxia and acute hypoxia. European Journal of Applied Physiology. 60(1). 1–6. 48 indexed citations
12.
Steinberg, Mitchell I., et al.. (1988). The Relation Between Vascular Relaxant and Cardiac Electrophysiological Effects of Pinacidil. Journal of Cardiovascular Pharmacology. 12(Supplement 2). S30–S40. 39 indexed citations
13.
Gengo, Peter J., Nancy Bowling, Virginia L. Wyss, & J S Hayes. (1988). Effects of prolonged phenylephrine infusion on cardiac adrenoceptors and calcium channels.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 100–105. 4 indexed citations
14.
Gengo, Peter J., Nancy Bowling, Virginia L. Wyss, & J S Hayes. (1988). Effects of prolonged phenylephrine infusion on cardiac adrenoceptors and calcium channels. Journal of Cardiothoracic Anesthesia. 2(4). 578–578. 34 indexed citations
15.
Hayes, J S, Virginia L. Wyss, Harve Wilson, David W. Robertson, & Raymond F. Kauffman. (1986). Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.. Journal of Pharmacology and Experimental Therapeutics. 239(2). 375–381. 3 indexed citations
16.
Robertson, David W., et al.. (1986). Dihydropyridazinone cardiotonics. The discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one. Journal of Medicinal Chemistry. 29(10). 1832–1840. 46 indexed citations
17.
Hayes, J S, et al.. (1986). Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists.. Journal of Pharmacology and Experimental Therapeutics. 237(3). 757–763. 33 indexed citations
18.
Wyss, Virginia L., et al.. (1985). A Comparison of the Cardiotonic Effects of AR-L115 and AR-L57. Journal of Cardiovascular Pharmacology. 7(1). 182–189. 7 indexed citations
19.
20.
Wyss, Virginia L.. (1956). [ECG of apneic subjects during immersion in water at various depths].. PubMed. 32(6). 503–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by YOSHIO YOSHIOKA Breakdown of academic impact, for papers by Snezana Mirkov Breakdown of academic impact, for papers by Arthur S. Brecher Breakdown of academic impact, for papers by B. H. Tan Breakdown of academic impact, for papers by Hongyu Qiu Breakdown of academic impact, for papers by N. Kitrossky Breakdown of academic impact, for papers by Pedro M. Politi Breakdown of academic impact, for papers by Gerhard H. Scholz Breakdown of academic impact, for papers by V. Monzani Breakdown of academic impact, for papers by Hideki Mitsuhashi
Rankless by CCL
2026